Scimago Lab
powered by Scopus
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


eISSN: 2329-0358

Get your full text copy in PDF

Factors Affeding Reactivation of Epstein-Barr Virus Infection after Kidney Allograft Transplantation

Zakieh Rostamzadeh Khameneh, Joanna Soin, Magdalena Durlik, Mieczyslaw Lao, Leszek Paczek, Zbigniew Gaciong

Ann Transplant 1999; 4(2): 18-22

ID: 497448

Objectives: Reactivation of Epstein-Barr virus (EBV) infection in renal transplant recipients may cause significant morbidity and mortality. To evaluate factors associated with activation of EBVreplication we followed prospectively a group of 65 recipients of cadaveric kidney for 12 months. Methods: Sera were collected periodically from these patients and analyzed for the presence of specific anti-EBV antibodies. Control group consisted of renal (n=35) and healthy blood donors (n=35). Enzyme-linked immunoassays based on recombinant EBVproteins were used to detect the following antibody specificities: early antigen (EA) 19A.IgM, and IgG, nuclear antigen (EBNA) IgG. Results: During first year after transplantation. primary infection developed in 4 (6.15%) recipients and reactivation occurred in 18 (27.7%) recipients. Analysis did not show the association of reactivation with type of basic immunosuppressive therapy, prophylactic or therapeutic use of anti-lymphocyte antibodies, as well as acute rejection episodes. There was a borderline association (p=O.068) between the incidence of CMV infection and EBVreactivation. Conclusions:Our data suggest casual relationship between CMV infection and EBVreactivation.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree